XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 255,371 $ 277,860
Restricted cash 74,877 73,441
Accounts receivable, net 25,427 27,124
Contract assets 6,498 6,478
Prepaid expenses and other current assets 50,196 40,288
Derivative asset, current portion 41,226 40,020
Equity method investment - marketable securities, at fair value 62,508 134,265
Total current assets 516,103 599,476
Property and equipment, net 1,301,732 1,338,787
Bitcoin 1,711,908 1,654,468
Restricted bitcoin 353,672  
Deposits 88,659 30,115
Finite-lived intangible assets, net 32,070 34,053
Derivative asset, less current portion 107,416 109,475
Operating lease right-of-use assets 30,803 27,492
Goodwill 122,499 121,887
Other long-term assets 20,539 19,554
Total assets 4,285,401 3,935,307
Current liabilities    
Accounts payable 18,057 17,609
Contract liabilities 21,601 9,644
Accrued expenses 70,006 75,672
Deferred gain on acquisition post-close dispute settlement   26,007
Deferred revenue, current portion 806 2,892
Contingent consideration liabilities, current portion 6,084 23,626
Current portion of debt 252,627 314
Operating lease liability, current portion 5,726 4,621
Total current liabilities 374,907 160,385
Deferred revenue, less current portion 243 13,590
Operating lease liability, less current portion 25,422 23,915
Contingent consideration liabilities, less current portion 3,129 3,229
Debt, less current portion 585,750 584,311
Other long-term liabilities 34 6,192
Total liabilities 989,485 791,622
Commitments and contingencies - Note 17
Stockholders' equity    
Preferred stock, no par value, 15,000,000 shares authorized:
2% Series A Convertible Preferred stock, 2,000,000 shares authorized; no shares issued and outstanding as of June 30, 2025 and December 31, 2024
0% Series B Convertible Preferred stock, 1,750,001 shares authorized; no shares issued and outstanding as of June 30, 2025 and December 31, 2024
Common stock, no par value; 680,000,000 shares authorized; 363,234,107 and 344,890,208 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 4,063,053 3,833,882
Accumulated deficit (767,332) (690,419)
Accumulated other comprehensive income (loss), net 195 222
Total stockholders' equity 3,295,916 3,143,685
Total liabilities and stockholders' equity $ 4,285,401 $ 3,935,307